HPV DNA TESTING: COBAS HPV TEST AS A FIRST-LINE CERVICAL CANCER SCREEN

Tracking # 20-457047

$99999.00

There are no ratings for this course

Educator ROCHE DIAGNOSTIC CORPORATION

CE Broker Reporting Reported automatically

Method Computer-Based Training

Course overview

For the last 60 years the primary method of preventing cervical cancer has been cervical cytology. HPV testing was added to cytology as a co-test for women 30 years and older. With the FDA approval of the Roche cobas HPV test for Primary screening with reflex to cytology a new option offers flexibility with demonstrated safety and effectiveness. 279-013-14